vadimezan has been researched along with Colorectal Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batubara, A; Carolan, VA; Clench, MR; Loadman, PM; Shnyder, SD; Sutton, C | 1 |
| Carlin, S; Ling, CC; Lorenzen, S; O'Donoghue, JA; Oehler, C; Russell, J; Zanzonico, P | 1 |
| Begent, RH; Boden, JA; Boden, R; Boxer, GM; Flynn, AA; Keep, PA; Pedley, RB | 1 |
| Begent, RH; Boden, R; Boxer, GM; Davies, L; Pedley, RB; Sharma, SK; Springer, CJ; Stribbling, SM | 1 |
4 other study(ies) available for vadimezan and Colorectal Cancer
| Article | Year |
|---|---|
Thin-layer chromatography/matrix-assisted laser desorption/ionisation mass spectrometry and matrix-assisted laser desorption/ionisation mass spectrometry imaging for the analysis of phospholipids in LS174T colorectal adenocarcinoma xenografts treated with
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromatography, Thin Layer; Colon; Colorectal Neoplasms; Male; Mice; Mice, Nude; Phospholipids; Rectum; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Xanthones | 2015 |
18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Colorectal Neoplasms; Female; HT29 Cells; Humans; Mice; Mice, Nude; Misonidazole; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Xanthones | 2011 |
Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Carcinoembryonic Antigen; Colorectal Neoplasms; Combined Modality Therapy; Flavonoids; Humans; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Radioimmunotherapy; Regional Blood Flow; Serotonin; Tissue Distribution; Transplantation, Heterologous; Xanthenes; Xanthones | 1996 |
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.
Topics: Animals; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; gamma-Glutamyl Hydrolase; Glutamates; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Nitrogen Mustard Compounds; Prodrugs; Transplantation, Heterologous; Xanthenes; Xanthones | 1999 |